Event JSON
{
"id": "a5e1d2bbecf9cc044ca7d2bbb9761b516d7780c8e56ac5f3dc0a4b5785568089",
"pubkey": "9c41d1165a76eda7abb3db9d665e67fdd23320dd1a8c6a65ff40a65935d667cc",
"created_at": 1736265993,
"kind": 1,
"tags": [
[
"r",
"https://www.cnbc.com/2025/01/07/jj-says-lung-cancer-drugs-rybrevant-and-lazcluze-extend-survival.html"
],
[
"subject",
"J\u0026J says its lung cancer drug combination keeps people alive longer"
],
[
"published_at",
"1736265573"
],
[
"image",
"https://image.cnbcfm.com/api/v1/image/106870814-1618920749172-gettyimages-1312652113-47938865.jpeg?v=1736265165\u0026w=1920\u0026h=1080"
],
[
"p",
"9c41d1165a76eda7abb3db9d665e67fdd23320dd1a8c6a65ff40a65935d667cc",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://image.cnbcfm.com/api/v1/image/106870814-1618920749172-gettyimages-1312652113-47938865.jpeg?v=1736265165\u0026w=1920\u0026h=1080"
],
[
"t",
"mainstream:perspective"
],
[
"summary",
"Johnson \u0026 Johnson's Rybrevant and Lazcluze regimen has demonstrated a clinically meaningful improvement in survival rate compared to AstraZeneca's Tagrisso in a pivotal trial. The regimen shows a statistically significant improvement in overall survival, with patients living at least a year longer than those taking Tagrisso. The company plans to present the full results at a medical meeting later this year. While the regimen comes with more side effects and requires infusions every few weeks, J\u0026J executives believe it will change the treatment of non-small cell lung cancer."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqn3qaz9j6wmk602anmwwkvhn8lhfrxgxar2xx5e0lgzn9jdwkvlxqy56fv4\nhttps://image.cnbcfm.com/api/v1/image/106870814-1618920749172-gettyimages-1312652113-47938865.jpeg?v=1736265165\u0026w=1920\u0026h=1080\nJohnson \u0026 Johnson said its lung cancer regimen – Rybrevant plus Lazcluze – keeps people alive for at least a year longer than AstraZeneca's Tagrisso.\nhttps://www.cnbc.com/2025/01/07/jj-says-lung-cancer-drugs-rybrevant-and-lazcluze-extend-survival.html",
"sig": "3835f22b3b0b114972680c4210b30aa3d279f1911056d7ed0ebb1077faf087eb17e1837d47f9474cd520fd1c7e6e2e95192cfda246f1c97aee55caac3fd4d444"
}
